CRISPR-Cas9 gene editing and human diseases

Area of Science:

• Biomedical Research
• Gene Editing Technology
• Therapeutic Development

Background:

• CRISPR/Cas9 is an innovative genome editing tool with therapeutic potential.
• Understanding gene modification and delivery is crucial for effective ex vivo research and treatment.
• Organ-specific gene correction necessitates comprehensive knowledge of genomic treatment methods.

Purpose of the Study:

• To review the significance of CRISPR/Cas9 delivery systems.
• To discuss synthetic (non-viral) and viral vector delivery systems.
• To summarize tissue-specific and organ-specific mRNA delivery for future research.

Main Methods:

• Review of existing literature on CRISPR/Cas9 delivery systems.
• Analysis of synthetic and viral vector approaches.
• Exploration of tissue-specific and organ-specific mRNA delivery.

Main Results:

• CRISPR/Cas9 delivery systems are vital for therapeutic applications.
• Both viral and non-viral systems offer distinct advantages for gene editing.
• Challenges include off-target effects, immunogenicity, and packaging limitations.

Conclusions:

• Efficient CRISPR/Cas9 delivery enables diverse clinical applications.
• The system shows promise for treating conditions like Intra Cerebral Haemorrhage (ICH).
• Further clinical trials are recommended for this breakthrough delivery system.